U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07300969) titled 'A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression' on Dec. 22.

Brief Summary: The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. Subjects will attend the clinic every couple of weeks complete general health checks and complete questionnaires.

Study Start Date: Dec. 16

Study Type: INTERVENTIONAL

Condition: Major Depressive Disorder (MDD)

Intervention: DRUG: DT-101

DT-101 A

DRUG: DT-101

DT-101 B

DRUG: Placebo

Placebo

Recruitment Status: RECRUITING

Sponsor: Draig Therapeutics Ltd

Disclaimer: Curated by HT Syndica...